IAVI and Biofabri are collaborating on the trial, which will recruit around 4,300 patients with latent TB infections across ...

Kenya is Among three African Countries that are set to participate in a medical trial by IAVI- a global research organisation ...

Commercial cattle farms in low-incidence bovine tuberculosis (TB) areas of England and Wales are being invited to participate ...

According to DOH, the BCG vaccine protects infants against tuberculosis. The letters B, C, and G stand for Bacillus ...

Spreading easily through the air, Mycobacterium tuberculosis can establish a chronic infection in human lungs, which can turn ...

As World Tuberculosis Day on March 24, 2025, approaches, global health authorities yet again find themselves at a crucial juncture in efforts to tackle the continuing global emergency of tuberculosis.

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

Spanish biopharmaceutical company Biofabri and nonprofit scientific research organization IAVI announced today that the first doses of tuberculosis (TB) vaccine candidate MTBVAC have been administered ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually. In a ...

In an interview with THE WEEK Dr Swapnil M. Khadake, HOD & Consultant Critical Care, Fortis Hiranandani Hospital talks about India’s TB elimination efforts and the future ahead ...